Speechmatics is a technology company.
Speechmatics has raised $69.0M across 2 funding rounds.
Speechmatics has raised $69.0M in total across 2 funding rounds.
Speechmatics has raised $69.0M in total across 2 funding rounds.
Speechmatics's investors include Albion VC, Illuminate Financial Management.
Speechmatics is a Cambridge-based technology company specializing in automatic speech recognition (ASR) software, delivering highly accurate speech-to-text APIs powered by deep learning and neural networks.[1][5][8] It serves enterprises across industries like media & entertainment, contact centers, CRM, financial services, security, healthcare, and software, solving the challenge of transcribing and understanding human speech in any context—handling accents, dialects, noise, multiple speakers, and over 40 languages with real-time capabilities.[2][3][4][8] The company processes millions of hours of audio monthly, offering deployment options on-premises, cloud, or edge, with products like the benchmark-setting Ursa engine (2023), Flow API for voice interactions (2024), and Autonomous Speech Recognition that outperforms major competitors like Amazon, Google, Apple, and Microsoft.[1][2][5]
Speechmatics demonstrates strong growth momentum through global expansion (offices in Czech Republic, USA, India), integrations like Microsoft Azure Marketplace (2021), investments from firms including Susquehanna Growth Equity, AlbionVC, IQ Capital, and Amadeus Capital Partners, and innovations in real-time transcription, medical models (e.g., Spanish launch), text-to-speech, and conversational AI.[1][2][5][8]
Founded in 2006 as Cantab Research Ltd by Dr. Tony Robinson, a speech recognition pioneer who applied neural networks to the problem in the 1980s at Cambridge University, Speechmatics emerged from decades of research in machine learning and ASR.[1][5] Robinson's expertise drove early innovations, evolving from statistical language modeling to recurrent neural networks and deep learning, with the company rebranding to Speechmatics to reflect its focus on scalable, inclusive speech technology.[1]
Pivotal moments include winning a Queen's Award for Enterprise in the Innovation Category for its Automatic Linguist tool, support from Cambridge Judge Business School's Accelerate Cambridge programme, and scaling investments starting in 2016 from IQ Capital and Amadeus Capital Partners, followed by AlbionVC and Susquehanna Growth Equity, which fueled international growth and product launches like Autonomous Speech Recognition in 2021.[1][5][6]
Speechmatics rides the explosive growth of AI-driven conversational interfaces, where speech becomes the dominant human-machine interaction amid rising demand for real-time audio analytics from video, calls, and agents.[5][6][8] Timing aligns with advancements in neural networks and self-supervised learning, enabling scalable ASR beyond English-centric limits, fueled by market forces like multilingual globalization, edge computing needs, and regulations favoring on-premises data sovereignty.[1][3][9]
It influences the ecosystem by enabling developers (100,000+ users) to build inclusive AI—e.g., LiveKit agents, Prosodica contact centers—and disrupting incumbents with higher accuracy in challenging scenarios, positioning speech tech as foundational for generative AI, healthcare transcription, and media searchability.[2][7][8]
Speechmatics is poised to dominate enterprise ASR with expansions into voice agents, medical transcription, and text-to-speech, leveraging its accuracy lead and global footprint.[8] Trends like low-latency edge AI, multimodal LLMs integrating speech, and non-English market growth will propel it, potentially capturing shares from Big Tech via specialized performance.[1][9] Its influence may evolve toward full speech platforms, closing the "humanity-machines gap" through every-voice understanding, building on a decade of outpacing rivals.[2][5]
Speechmatics has raised $69.0M across 2 funding rounds. Most recently, it raised $61.0M Series B in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2022 | $61.0M Series B | Albion VC, Illuminate Financial Management | |
| Oct 1, 2019 | $8.0M Series A | Albion VC, Illuminate Financial Management |